Send me a link:

*Text messaging rates may apply.

 Dow Down 0.02% Nasdaq Down 0.04%

Keryx Biopharmaceuticals Inc. (KERX)

-NasdaqCM
14.86 0.18(1.23%) Jul 24, 4:00PM EDT
Prev Close:14.68
Open:14.76
Bid:15.39 x 600
Ask:15.55 x 200
1y Target Est:24.00
Beta:4.23
Earnings Date:Jul 28 - Aug 1 (Est.)
Day's Range:14.46 - 14.97
52wk Range:8.29 - 17.46
Volume:1,137,150
Avg Vol (3m):1,678,000
Market Cap:1.36B
P/E (ttm):N/A
EPS (ttm):-0.70
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for KERX

Comparison

Symbol% ChgMkt Cap
KERXUp 1.23%1.36B
BAX41.78B
SHPG49.44B

Key Statistics

Forward P/E (1 yr):74.30
P/S (ttm):134.25
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.79
Quarterly EPS Est (Jun-14) :-0.25
Mean Recommendation*:1.6
PEG Ratio (5 yr expected):-0.60

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Keryx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of pharmaceutical products for the treatment of renal disease in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback